Schedule of Significant Segment Expenses (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Research and development	$ 772,702	$ 279,489
Operating expenses	3,623,142	3,823,626
Sale of royalty and milestone rights, net of transaction costs	2,000,000	4,167,219
Net income (loss)	(1,589,685)	400,443
Other Operating Segment [Member]
Segment Reporting Information [Line Items]
Revenue
Research and development	(772,702)	(279,489)
Payroll and related	(1,093,327)	(1,174,239)
Insurance	(209,922)	(674,976)
Professional fees primarily related to intellectual property	(895,682)	(963,926)
Operating expenses	(651,509)	(730,996)
Sale of royalty and milestone rights, net of transaction costs	2,000,000	4,167,219
Other income	33,456	56,850
Net income (loss)	$ (1,589,686)	$ 400,443